Egyesült Államok - angol - NLM (National Library of Medicine)

nucare pharmaceuticals, inc. - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - acetaminophen 300 mg - acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain,where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] - have not provided adequate analgesia, or are not expected to provide adequate analgesia - have not been tolerated, or are not expected to be tolerated acetaminophen and codeine phosphate tablets are contraindicated in patients with: - patients with significant respiratory depression [see warnings].  - patients with acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings].  - postoperative pain management in children who have undergone tonsillectomy and/or adenoidectomy [

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

fit-bioceuticals limited - ascorbic acid,betacarotene,biotin,calcium pantothenate,calcium phosphate,choline bitartrate,chromium nicotinate,colecalciferol,d-alpha-tocopheryl acid succinate,inositol,levomefolate calcium,magnesium phosphate pentahydrate,manganese amino acid chelate,mecobalamin (co-methylcobalamin),menaquinone 7,molybdenum trioxide,nicotinamide,nicotinic acid,potassium iodide,pyridoxal 5-phosphate monohydrate,pyridoxine hydrochloride,riboflavin sodium phosphate,selenomethionine,thiamine -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

fit-bioceuticals limited - ascorbic acid,betacarotene,biotin,calcium folinate,calcium pantothenate,calcium phosphate,choline bitartrate,chromium nicotinate,colecalciferol,cyanocobalamin,d-alpha-tocopheryl acid succinate,inositol,levomefolate calcium,magnesium phosphate pentahydrate,manganese amino acid chelate,mecobalamin (co-methylcobalamin),menaquinone 7,molybdenum trioxide,nicotinamide,nicotinic acid,potassium iodide,pyridoxal 5-phosphate monohydrate,pyridoxine hydrochloride,riboflavin,riboflavin sodium -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

fit-bioceuticals limited - ascorbic acid,borax,biotin,calcium folinate,calcium pantothenate,calcium phosphate,choline bitartrate,chromium nicotinate,colecalciferol,cyanocobalamin,d-alpha-tocopheryl acid succinate,inositol,levomefolate calcium,magnesium phosphate pentahydrate,manganese amino acid chelate,mecobalamin (co-methylcobalamin),menaquinone 7,molybdenum trioxide,nicotinamide,nicotinic acid,potassium iodide,pyridoxal 5-phosphate monohydrate,pyridoxine hydrochloride,punica granatum,retinol -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

fit-bioceuticals limited - ascorbic acid,borax,biotin,calcium citrate tetrahydrate,calcium folinate,calcium pantothenate,choline bitartrate,chromium picolinate,colecalciferol,copper gluconate,cyanocobalamin,d-alpha-tocopheryl acetate,inositol,levomefolate calcium,lycopene,magnesium phosphate pentahydrate,manganese amino acid chelate,mecobalamin (co-methylcobalamin),menaquinone 7,molybdenum trioxide,nicotinamide,nicotinic acid,potassium iodide,pyridoxal 5-phosphate monohydrate,pyridoxine hydrochloride,retinol -

Egyesült Államok - angol - NLM (National Library of Medicine)

aurolife pharma, llc - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - acetaminophen 300 mg - acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain,where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] •have not provided adequate analgesia, or are not expected to provide adequate analgesia •have not been tolerated, or are not expected to be tolerated acetaminophen and codeine phosphate tablets are contraindicated for: - all children younger than 12 years of age (see warnings ). - post-operative management in children younger than 18 years of age following tonsillectomy and/or adenoidectomy (see warnings ).  acetaminophen and codeine phosphate tablets are contraindicated in patients with:  - significant respiratory depression [seewarnings ]. -

Egyesült Államok - angol - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - acetaminophen 300 mg - acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain,where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] •have not provided adequate analgesia, or are not expected to provide adequate analgesia •have not been tolerated, or are not expected to be tolerated acetaminophen and codeine phosphate tablets are contraindicated for: acetaminophen and codeine phosphate tablets are contraindicated in patients with:  controlled substance acetaminophen and codeine phosphate tablets contain codeine. codeine in combination with acetaminophen, is a schedule iii controlled substance. abuse acetaminophen and codeine phosphate tablets contain codeine, a sub

Egyesült Államok - angol - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - acetaminophen 300 mg - acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain, where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] - have not provided adequate analgesia, or are not expected to provide adequate analgesia, - have not been tolerated, or are not expected to be tolerated. acetaminophen and codeine phosphate tablets are contraindicated for: - all children younger than 12 years of age [see warnings ]. - post-operative management in children younger than 18 years of age following tonsillectomy and/or adenoidectomy [see warnings ]. acetaminophen and codeine phosphate tablets are contraindicated in patients with: - significant respiratory depression [see warnings ].

Egyesült Államok - angol - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - acetaminophen 300 mg - acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain, where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] acetaminophen and codeine phosphate tablets are contraindicated for: acetaminophen and codeine phosphate tablets are contraindicated in patients with: acetaminophen and codeine phosphate tablets contain codeine. codeine in combination with acetaminophen, a schedule iii controlled substance. acetaminophen and codeine phosphate tablets contain codeine, a substance with a high potential for abuse similar to other opioids, including fentanyl, hydrocodone, hydromorphone, methadone, morphine, oxycodone, oxymorphone, and tapentadol. acetaminophen and c

Egyesült Államok - angol - NLM (National Library of Medicine)

redpharm drug - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - acetaminophen 300 mg - acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses (see warnings), reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics) have not provided adequate analgesia, or are not expected to provide adequate analgesia, have not been tolerated, or are not expected to be tolerated. acetaminophen and codeine phosphate tablets are contraindicated in: patients with significant respiratory depression (see warnings). patients with acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment (see warnings). postoperative pain management in children who have undergone tonsillectomy and/or adenoidectomy (see warnings). patients with known or